Kate Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 48

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.13B

Kate Therapeutics General Information

Description

Operator of a patient-focused biotechnology company intended to develop adeno-associated virus-based gene therapies to treat genetically defined muscle diseases. The company's novel capsids provide superior muscle transduction and liver de-targeting, above and beyond naturally occurring serotypes currently in clinical trials, this enables complete tissue transduction at significantly lower viral doses, thus addressing one of the major headwinds facing muscle gene delivery, enabling Patients with superior muscle and heart transduction and liver de-targeting compared to the naturally occurring serotypes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 10675 Sorrento Valley Road
  • Suite 150
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 10675 Sorrento Valley Road
  • Suite 150
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kate Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 31-Oct-2024 $1.13B Completed Generating Revenue
2. Early Stage VC (Series B1) 07-Aug-2024 Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 08-Jun-2023 $51M $51M Completed Pre-Clinical Trials
To view Kate Therapeutics’s complete valuation and funding history, request access »

Kate Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1
Series A-1
Series A 16,000,000 $0.000010 8% $1 $1 1x $1 22.88%
To view Kate Therapeutics’s complete cap table history, request access »

Kate Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a patient-focused biotechnology company intended to develop adeno-associated virus-based gene therapies to t
Drug Discovery
San Diego, CA
48 As of 2024

South San Francisco, CA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kate Therapeutics Competitors (3)

One of Kate Therapeutics’s 3 competitors is Tenaya Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tenaya Therapeutics Formerly VC-backed South San Francisco, CA
Verve Therapeutics Formerly VC-backed Boston, MA
Vasa Therapeutics Venture Capital-Backed Encinitas, CA
You’re viewing 3 of 3 competitors. Get the full list »

Kate Therapeutics Patents

Kate Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026050402-A1 Liver de-targeted muscle tropic capsids Pending 29-Aug-2024
WO-2026030244-A1 Adeno-associated virus compositions for the treatment of limb girdle muscular dystrophy 2a Pending 30-Jul-2024
US-20260275379-A1 Adeno-associated virus compositions for the treatment of facioscapulohumeral muscular dystrophy Pending 29-Jul-2024
WO-2026030242-A1 Adeno-associated virus compositions for the treatment of facioscapulohumeral muscular dystrophy Pending 29-Jul-2024
WO-2026011009-A1 Compositions and methods for muscle disorders Pending 02-Jul-2024 C12N15/113
To view Kate Therapeutics’s complete patent history, request access »

Kate Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kate Therapeutics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
UF Innovate Ventures Accelerator/Incubator Minority
Versant Ventures Venture Capital Minority
Westlake Village BioPartners Venture Capital Minority
To view Kate Therapeutics’s complete investors history, request access »

Kate Therapeutics FAQs

  • When was Kate Therapeutics founded?

    Kate Therapeutics was founded in 2020.

  • Where is Kate Therapeutics headquartered?

    Kate Therapeutics is headquartered in San Diego, CA.

  • What is the size of Kate Therapeutics?

    Kate Therapeutics has 48 total employees.

  • What industry is Kate Therapeutics in?

    Kate Therapeutics’s primary industry is Drug Discovery.

  • Is Kate Therapeutics a private or public company?

    Kate Therapeutics is a Private company.

  • What is the current valuation of Kate Therapeutics?

    The current valuation of Kate Therapeutics is .

  • What is Kate Therapeutics’s current revenue?

    The current revenue for Kate Therapeutics is .

  • How much funding has Kate Therapeutics raised over time?

    Kate Therapeutics has raised $72.8M.

  • Who are Kate Therapeutics’s investors?

    UF Innovate Ventures, Versant Ventures, and Westlake Village BioPartners have invested in Kate Therapeutics.

  • Who are Kate Therapeutics’s competitors?

    Tenaya Therapeutics, Verve Therapeutics, and Vasa Therapeutics are competitors of Kate Therapeutics.

  • When was Kate Therapeutics acquired?

    Kate Therapeutics was acquired on 31-Oct-2024.

  • Who acquired Kate Therapeutics?

    Kate Therapeutics was acquired by Novartis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process